Cannabis Report
Home > Boards > US Listed > Mining/Resources >

India Globalization Capital Inc (IGC)

IGC RSS Feed
Add IGC Price Alert      Hide Sticky   Hide Intro
Moderator: CrazyKar123
Search This Board: 
Last Post: 9/22/2018 12:37:46 PM - Followers: 120 - Board type: Free - Posts Today: 5

India Globalization Capital, Inc. (NYSE MKT: IGC) is a first mover in developing a portfolio of products using cannabis-based "combination therapies" for the treatment of pain and other conditions.

IGC's strategy is exciting and unique in that it is aiming to become a leader in the phytocannabinoid-based combination therapy specialty pharmaceutical sector. This first-mover advantage can potentially be formidable as it begins clinical trials and further builds its patent portfolio

IGC recently exited its legacy businesses and currently holds international investments in land and in a hotel project.

 

Investment Highlights

• Building a patented portfolio of phytocannabinoid-based pharmaceutical and nutraceutical products for one of the world's fastest growing industries
• Positioning for first-mover advantage by developing novel therapies, applying for patents, and acquiring technologies from related industries
• Strategic alliance with International Pharma Trials provides expertise in the FDA process and pharma-trials

 


Development Pipeline

Through cutting-edge research, IGC is developing a product portfolio of phytocannabinoid-based therapies for the treatment of a wide range of life altering or life threatening indications, including neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis.


Target Markets

Attitudes toward cannabis have transformed substantially across the United States. Support for cannabis legalization is rapidly outpacing opposition; 53 percent of Americans believe cannabis should be made legal, compared with 44 percent supporting illegality of cannabis. Within this burgeoning market, IGC has identified key areas to which it can apply its phytocannabinoid-based therapies to address unmet medical needs.

 

Pain

The treatment of pain is a great challenge for health care professionals as it can often debilitate individuals in ways that affect their day-to-day functioning, which significantly impacts the nation's productivity and economy. The national cost of health care due to pain ranges from $560 billion to $635 billion. In addition, the health care cost attributed to the abuse of prescription opioids, closely related to pain, is approximately $25 billion.

A major disadvantage of using currently available drug therapies to treat chronic severe pain is that these opioid based drugs may lead to side effects like hallucinations, constipation, sedation, nausea, respiratory depression, and dysphoria.

IGC-501

IGC has applied for a U.S patent based on a novel therapy, IGC-502 indicated for seizures, using cannabinoid extracts. The therapy is administered, using a variety of delivery technologies, for indications in mammals such as dogs and cats. The therapy may also be useful in humans.

IGC expects to conduct metabolic profiling and apply to the FDA for trials over the next few years.

 

Epilepsy

Approximately 50 million people worldwide are affected by epilepsy (Sanders, 2003), a condition attributed to multiple factors. In dogs and cats, seizures are often caused by abnormal brain activity. They can be subtle or cause violent convulsions. Some seizures only occur once, but repeated seizures require treatment to prevent larger areas of the brain from becoming affected.

IGC-502

IGC has applied for a U.S patent based on a novel therapy, IGC-502 indicated for seizures, using cannabinoid extracts. The therapy is administered, using a variety of delivery technologies, for indications in mammals such as dogs and cats. The therapy may also be useful in humans.

IGC expects to conduct metabolic profiling and apply to the FDA for trials over the next few years.

 

Eating Disorders

Cachexia is a condition that accompanies severe illness such as cancer and results in the weakness and wasting away of the body. Approximately 1.3 million people in the United States are experiencing cachexia associated with cancer, multiple sclerosis, Parkinson's disease, HIV/AIDS, and other progressive illnesses. Notably, cancer-induced anorexia/cachexia is responsible for about 20% of all cancer deaths.

IGC-504 and IGC-506

Indicated for a variety of eating disorders, including cachexia, IGC-504 and IGC 506 are unique combination therapies that, if proven out by clinical trials, are expected to treat medical refractory epilepsy and eating disorders respectively, with lower side effects than conventional mono therapies. IGC-506 is being developed for both human and veterinary use.

 


Industry Partnerships

IGC has established a strategic alliance with International Pharma Trials, whose doctors and researchers have expertise in disorders of the central and peripheral nervous system as well as expertise in the FDA process and pharma-trials.

The company continues to seek information exchanges with medical cannabis dispensaries, research scientists, doctors, medical and business professionals, and biotech companies working in the cannabinoid space.

Leveraging its business model and collaborative research, IGC can help commercialize products while finding innovative ways of helping patients benefit from cannabinoids.

 


Leadership


Ram Mukunda, President, CEO and Director

Ram Mukunda has served as IGC's executive chairman, chief executive officer, and president since the company's inception on April 29, 2005. From January 1990 to May 2004, Mukunda served as founder, chairman, and chief executive officer of Startec Global Communications, an international telecommunications carrier focused on providing voice over Internet protocol (VOIP) services to emerging economies. Startec was the first pure play international long distance carrier. Mukunda was responsible for organizing, structuring and integrating a number of companies owned by Startec. Under Mukunda's tenure at Startec, the company made an IPO of its equity securities in 1997 on NASDAQ. Prior to Startec, Mr. Mukunda served as Strategic Planning Advisor at Intelsat, a communications satellite services provider.

Mukunda serves as an emeritus member on the Board of Visitors at the University of Maryland, School of Engineering. From 2001 to 2003, he was a council member at Harvard's Kennedy School of Government, Belfer Center of Science and International Affairs.

Mukunda is the recipient of several awards including, the 2013 University of Maryland's International Alumnus of the Year award, the 2001 Distinguished Engineering Alumnus Award, the 1998 Ernst & Young, LLP's Entrepreneur of the Year Award. He holds a B.S. degree in Electrical Engineering, a B.S degree in Mathematics, and a M.S. in Engineering from the University of Maryland.

John Cherin, CFO, Treasurer, PAO

John Cherin is a retired senior executive with international experience in assisting young companies. He has provided insight to top management and Board of Directors on strategic analysis and improvement of operating procedures in financial reporting and operations. From 1966 to 1997, Cherin gained his experience as a senior partner at Arthur Andersen while managing practices aimed at businesses in the US and overseas. In addition he founded and managed Cherin Global Consulting in 1997-2005 and the Cherin Group LLC in 2004 to date. He also served as CFO for IGC in its formative stages for the purpose of raising capital to enable IGC's launch in the post startup phase.

Cherin is a retired CPA, a graduate of Northeastern University class of 1966 and in 1967 was the Silver Medal Recipient from the Massachusetts Society of CPAs.

Claudia Grimaldi, General Manager, Director of Cabaran Ultima

Claudia Grimaldi is the general manager and director of IGC's project development and managing company in Malaysia. Grimaldi is responsible for coordinating the staff in various countries and ensuring timely and accurate regulatory compliance and statutory reporting. Prior to assuming her current role in 2013, she spent three years managing the office of the CEO.

Prior to IGC, Grimaldi worked in human resources and psychotherapy. She graduated Summa Cum Laude from Javeriana University, a top five University in Colombia, with a Bachelor of Arts in Psychology. She holds an MBA in General Management, graduating with Highest Honors, from Meredith College. Grimaldi is a member of Delta Mu Delta International Honor Society. She is also fluent in both English and Spanish.

 


India Globalization Capital
PO BOX 60642
Potomac, MD 20859-0642
Phone: (301) 983-0998
www.IGCinc.us

NetworkNewsWire
1324 Lexington Ave.
Suite 117
New York, NY 10128
Phone: (212) 418-1217
www.NetworkNewsWire.com

 

NetworkNewsWire is a moderator of this board. Please see disclaimer on the NetworkNewsWire website: https://www.networknewswire.com/disclaimer/

Cannabis Report
IGC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IGC News: Current Report Filing (8-k) 09/12/2018 04:33:52 PM
IGC News: Statement of Changes in Beneficial Ownership (4) 08/31/2018 06:56:41 PM
IGC News: Statement of Changes in Beneficial Ownership (4) 08/31/2018 06:55:08 PM
IGC News: Statement of Changes in Beneficial Ownership (4) 08/29/2018 07:53:24 PM
IGC News: Statement of Changes in Beneficial Ownership (4) 08/29/2018 06:50:21 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#5336  Sticky Note India Globalization Capital Inc (IGC) August 29, 2018 CrazyKar123 08/30/18 08:48:40 AM
#5421   Anyone here think Monday will be another Green Irishmick8299 09/22/18 12:37:46 PM
#5420   Hope you’re having a nice sesh this weekend vplm4life 09/22/18 11:45:55 AM
#5419   You got it son sorkin 09/22/18 07:07:38 AM
#5418   “Piggy Bank” for Ram Mukunda! He takes every opportunity sorkin 09/22/18 07:05:32 AM
#5417   https://www.barchart.com/stocks/quotes/IGC/opinion 100 percent buy rating on bar Lynns25 09/22/18 12:53:31 AM
#5416   glad all mine are free he he he!!! poor500 09/21/18 04:43:41 PM
#5415   nice ride this was to 4, 12k made fireballka7 09/21/18 04:34:55 PM
#5414   Stellar squeeze today... patience paid off. UP Trend 09/21/18 04:34:14 PM
#5413   * * $IGC Video Chart 09-21-18 * * ClayTrader 09/21/18 04:33:08 PM
#5412   <<\¯_¯_\_¯_¯_¯\_¯_¯_\¯_¯_\¯_¯¯_&#1 pj McMulligan 09/21/18 04:22:17 PM
#5411   Tough filling IGCIW, they only gave a partial pj McMulligan 09/21/18 04:18:49 PM
#5410   Oh don't forget the S1 they filed which Sprycel 09/21/18 04:10:47 PM
#5409   You all got RAM'd!!! LOL! He Sprycel 09/21/18 04:07:29 PM
#5408   Fear not. Happens towards end of day. Doomsday1965 09/21/18 04:03:22 PM
#5407   what a day, bummer last hour! poor500 09/21/18 03:53:20 PM
#5406   yep $MNGA is getting started too ties to John Kent 09/21/18 02:45:16 PM
#5405   Going to 10.00 plus vplm4life 09/21/18 02:08:14 PM
#5404   IGC About time this IGC message board lit instock58 09/21/18 12:29:27 PM
#5403   The warrants are still DOWN! IGCIW. hottip1 09/21/18 12:03:51 PM
#5402   Glad to see it running again! Curt D 09/21/18 11:37:36 AM
#5401   Shares outstanding is 31 million? PePe Le Profit 09/21/18 11:37:02 AM
#5400   46M volume trying for $4 again [SMART MONEY] 09/21/18 11:34:20 AM
#5399   Don't forget about the $20 million S1 the Sprycel 09/21/18 11:32:48 AM
#5398   I just jumped in on this little pullback. Curt D 09/21/18 10:34:11 AM
#5397   FOMO + MOMO = $$$$$ > IGC crudeoil24 09/21/18 09:57:58 AM
#5396   sold 1/2 about a month ago so all poor500 09/21/18 09:57:57 AM
#5395   MASSIVE VOLUME!!!!! crudeoil24 09/21/18 09:57:24 AM
#5394   What a huge rocketship! crudeoil24 09/21/18 09:53:36 AM
#5393   Weeeee! Beast mode. UP Trend 09/21/18 09:50:59 AM
#5392   Why does igciw not following its footstep??? Amber786 09/21/18 09:30:07 AM
#5391   Looks like nbev money moving into this one.. UP Trend 09/21/18 09:10:51 AM
#5390   I'm already in, and glad. This may eebbee 09/21/18 07:05:51 AM
#5389   took a position in this today. chart looks good. fireballka7 09/20/18 04:09:49 PM
#5388   IGC UP 25% Actually looks like its Accelerating instock58 09/20/18 03:54:28 PM
#5387   Mmj mania, TLRY money is flowing into other UP Trend 09/20/18 03:51:27 PM
#5386   I bought IGC on a whim! Wasn't Doomsday1965 09/20/18 09:30:37 AM
#5385   IGC Up 19% Pre Market. A "Runner" today?? Could instock58 09/20/18 08:50:56 AM
#5384   Wow! Here I am gawking at my Namaste Doomsday1965 09/20/18 08:43:27 AM
#5383   1.97 premarket eebbee 09/20/18 08:02:57 AM
#5382   * * $IGC Video Chart 09-19-18 * * ClayTrader 09/19/18 06:54:18 PM
#5381   IGC and so Much More $$$ coming to instock58 09/19/18 05:50:20 PM
#5380   I really need to find time to research Doomsday1965 09/19/18 11:34:24 AM
#5379   * * $IGC Video Chart 09-18-18 * * ClayTrader 09/18/18 04:47:16 PM
#5378   Yes indeed! :) Doomsday1965 09/18/18 04:02:47 PM
#5377   On the move again.. UP Trend 09/18/18 01:00:10 PM
#5376   Same here. TINY until I've researched this stock Doomsday1965 09/11/18 08:27:05 AM
#5375   Back in with tiny starter.. UP Trend 09/10/18 12:52:11 PM
#5374   * * $IGC Video Chart 09-07-18 * * ClayTrader 09/07/18 04:33:18 PM
#5373   I ran... Doomsday1965 09/07/18 01:35:30 PM
#5372   Run! @WolfofWeedST 09/07/18 01:02:11 PM
PostSubject